Motif ID: MYOD1
Z-value: 1.821
Transcription factors associated with MYOD1:
| Gene Symbol | Entrez ID | Gene Name |
|---|---|---|
| MYOD1 | ENSG00000129152.3 | MYOD1 |
Top targets:
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.8 | 14.1 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
| 1.5 | 8.9 | GO:0007525 | somatic muscle development(GO:0007525) |
| 1.3 | 6.7 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 1.3 | 4.0 | GO:1903115 | regulation of muscle filament sliding(GO:0032971) regulation of actin filament-based movement(GO:1903115) |
| 1.1 | 6.9 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
| 1.0 | 3.8 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.7 | 18.7 | GO:0043462 | regulation of ATPase activity(GO:0043462) |
| 0.6 | 1.8 | GO:0002514 | B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
| 0.6 | 2.9 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.5 | 1.6 | GO:0002124 | territorial aggressive behavior(GO:0002124) brainstem development(GO:0003360) vocalization behavior(GO:0071625) |
| 0.4 | 1.8 | GO:0044854 | membrane raft assembly(GO:0001765) nitric oxide homeostasis(GO:0033484) negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) membrane assembly(GO:0071709) |
| 0.3 | 0.6 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
| 0.3 | 1.3 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.3 | 14.6 | GO:0030049 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.3 | 3.0 | GO:0031017 | exocrine pancreas development(GO:0031017) |
| 0.3 | 2.5 | GO:0071692 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
| 0.3 | 4.5 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
| 0.3 | 2.9 | GO:0006600 | creatine metabolic process(GO:0006600) |
| 0.2 | 1.2 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
| 0.2 | 18.3 | GO:0007519 | skeletal muscle tissue development(GO:0007519) |
| 0.2 | 0.9 | GO:0071071 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) regulation of phospholipid biosynthetic process(GO:0071071) |
| 0.2 | 1.1 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
| 0.2 | 3.6 | GO:0045749 | obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
| 0.2 | 0.6 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.2 | 0.6 | GO:0060279 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
| 0.2 | 4.1 | GO:0034605 | cellular response to heat(GO:0034605) |
| 0.2 | 2.5 | GO:0006527 | arginine catabolic process(GO:0006527) |
| 0.2 | 1.1 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 0.2 | 1.4 | GO:0010799 | regulation of peptidyl-threonine phosphorylation(GO:0010799) positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
| 0.2 | 1.1 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
| 0.1 | 1.7 | GO:0031529 | ruffle organization(GO:0031529) |
| 0.1 | 2.1 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.1 | 5.6 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
| 0.1 | 2.8 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
| 0.1 | 1.0 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
| 0.1 | 0.4 | GO:0015705 | iodide transport(GO:0015705) |
| 0.1 | 0.4 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
| 0.1 | 0.2 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
| 0.1 | 0.3 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 0.1 | 0.8 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) carnitine metabolic process(GO:0009437) |
| 0.1 | 0.3 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
| 0.1 | 3.3 | GO:0051318 | G1 phase(GO:0051318) |
| 0.1 | 0.3 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.1 | 0.9 | GO:0071333 | cellular response to monosaccharide stimulus(GO:0071326) cellular response to hexose stimulus(GO:0071331) cellular response to glucose stimulus(GO:0071333) |
| 0.1 | 0.2 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
| 0.0 | 0.2 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
| 0.0 | 4.4 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
| 0.0 | 0.5 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
| 0.0 | 1.4 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
| 0.0 | 0.4 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
| 0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.0 | 0.7 | GO:0045103 | intermediate filament-based process(GO:0045103) |
| 0.0 | 0.9 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
| 0.0 | 0.1 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
| 0.0 | 0.1 | GO:0015917 | aminophospholipid transport(GO:0015917) |
| 0.0 | 0.3 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.0 | 1.2 | GO:0016486 | peptide hormone processing(GO:0016486) |
| 0.0 | 2.4 | GO:0009408 | response to heat(GO:0009408) |
| 0.0 | 0.1 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
| 0.0 | 0.1 | GO:1903332 | regulation of protein folding(GO:1903332) |
| 0.0 | 0.8 | GO:0001578 | microtubule bundle formation(GO:0001578) |
| 0.0 | 0.2 | GO:0009136 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
| 0.0 | 0.9 | GO:0070542 | response to fatty acid(GO:0070542) |
| 0.0 | 2.6 | GO:0008016 | regulation of heart contraction(GO:0008016) |
| 0.0 | 1.1 | GO:0042493 | response to drug(GO:0042493) |
| 0.0 | 0.2 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.0 | 1.0 | GO:0046847 | filopodium assembly(GO:0046847) |
| 0.0 | 0.1 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of cell junction assembly(GO:1901889) negative regulation of adherens junction organization(GO:1903392) |
| 0.0 | 0.6 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
| 0.0 | 0.8 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
| 0.0 | 0.1 | GO:0061303 | iris morphogenesis(GO:0061072) cornea development in camera-type eye(GO:0061303) |
| 0.0 | 5.3 | GO:0007015 | actin filament organization(GO:0007015) |
| 0.0 | 0.2 | GO:0006561 | proline biosynthetic process(GO:0006561) |
| 0.0 | 0.1 | GO:1904396 | regulation of synaptic growth at neuromuscular junction(GO:0008582) regulation of neuromuscular junction development(GO:1904396) |
| 0.0 | 0.9 | GO:0006308 | DNA catabolic process(GO:0006308) |
| 0.0 | 0.6 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
| 0.0 | 0.2 | GO:0032956 | regulation of actin cytoskeleton organization(GO:0032956) |
| 0.0 | 0.2 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 0.0 | 0.2 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.0 | 0.9 | GO:0015914 | phospholipid transport(GO:0015914) |
| 0.0 | 3.5 | GO:0007517 | muscle organ development(GO:0007517) |
| 0.0 | 0.1 | GO:0015670 | carbon dioxide transport(GO:0015670) saliva secretion(GO:0046541) |
| 0.0 | 0.5 | GO:0030866 | cortical cytoskeleton organization(GO:0030865) cortical actin cytoskeleton organization(GO:0030866) |
| 0.0 | 0.5 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.0 | 0.1 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) |
| 0.0 | 0.4 | GO:0002076 | osteoblast development(GO:0002076) |
| 0.0 | 0.3 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) positive regulation of granulocyte differentiation(GO:0030854) |
| 0.0 | 0.6 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
| 0.0 | 0.3 | GO:0001952 | regulation of cell-matrix adhesion(GO:0001952) |
| 0.0 | 0.7 | GO:0006446 | regulation of translational initiation(GO:0006446) |
| 0.0 | 3.1 | GO:0050900 | leukocyte migration(GO:0050900) |
| 0.0 | 3.0 | GO:0050658 | nucleic acid transport(GO:0050657) RNA transport(GO:0050658) establishment of RNA localization(GO:0051236) |
| 0.0 | 1.1 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
| 0.0 | 0.2 | GO:0017158 | regulation of calcium ion-dependent exocytosis(GO:0017158) |
| 0.0 | 0.3 | GO:0006386 | transcription elongation from RNA polymerase III promoter(GO:0006385) termination of RNA polymerase III transcription(GO:0006386) |
| 0.0 | 0.8 | GO:0008360 | regulation of cell shape(GO:0008360) |
| 0.0 | 0.9 | GO:0051084 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
| 0.0 | 0.1 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
| 0.0 | 0.8 | GO:0006921 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) execution phase of apoptosis(GO:0097194) |
| 0.0 | 0.3 | GO:0006310 | DNA recombination(GO:0006310) |
| 0.0 | 0.1 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.9 | 22.2 | GO:0005861 | troponin complex(GO:0005861) |
| 0.9 | 25.0 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 0.6 | 12.4 | GO:0036379 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
| 0.6 | 13.7 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.5 | 2.7 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
| 0.4 | 3.6 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
| 0.3 | 1.8 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 0.3 | 15.2 | GO:0030018 | Z disc(GO:0030018) |
| 0.3 | 4.8 | GO:0031674 | I band(GO:0031674) |
| 0.2 | 9.6 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.2 | 3.4 | GO:0001527 | microfibril(GO:0001527) |
| 0.2 | 1.6 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
| 0.2 | 1.9 | GO:0030425 | dendrite(GO:0030425) |
| 0.2 | 7.5 | GO:0030017 | sarcomere(GO:0030017) |
| 0.1 | 1.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.1 | 4.9 | GO:0098636 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
| 0.1 | 0.9 | GO:0001950 | obsolete plasma membrane enriched fraction(GO:0001950) |
| 0.1 | 0.3 | GO:0000124 | SAGA complex(GO:0000124) |
| 0.1 | 0.4 | GO:0045179 | apical cortex(GO:0045179) |
| 0.1 | 0.6 | GO:0016012 | sarcoglycan complex(GO:0016012) |
| 0.1 | 1.8 | GO:0005811 | lipid particle(GO:0005811) |
| 0.1 | 0.8 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
| 0.0 | 0.2 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
| 0.0 | 1.4 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.0 | 0.4 | GO:0005638 | lamin filament(GO:0005638) |
| 0.0 | 0.5 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.0 | 3.6 | GO:0030426 | growth cone(GO:0030426) |
| 0.0 | 3.4 | GO:0005802 | trans-Golgi network(GO:0005802) |
| 0.0 | 1.3 | GO:0005902 | microvillus(GO:0005902) |
| 0.0 | 3.7 | GO:0070160 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
| 0.0 | 0.6 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.0 | 1.7 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
| 0.0 | 0.7 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.0 | 0.5 | GO:0030315 | T-tubule(GO:0030315) |
| 0.0 | 0.2 | GO:0098645 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
| 0.0 | 0.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
| 0.0 | 3.0 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.0 | 0.2 | GO:0032982 | myosin filament(GO:0032982) |
| 0.0 | 0.5 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 0.0 | 0.2 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
| 0.0 | 0.2 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.0 | 0.9 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
| 0.0 | 0.4 | GO:0030175 | filopodium(GO:0030175) |
| 0.0 | 4.0 | GO:0015629 | actin cytoskeleton(GO:0015629) |
| 0.0 | 2.3 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
| 0.0 | 0.7 | GO:0001726 | ruffle(GO:0001726) |
| 0.0 | 0.7 | GO:0015030 | Cajal body(GO:0015030) |
| 0.0 | 0.1 | GO:0008537 | proteasome activator complex(GO:0008537) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.9 | 7.7 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
| 1.1 | 12.6 | GO:0031013 | troponin I binding(GO:0031013) |
| 1.1 | 9.8 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
| 0.9 | 14.1 | GO:0042166 | acetylcholine binding(GO:0042166) |
| 0.9 | 5.1 | GO:0097493 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
| 0.5 | 3.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.5 | 2.5 | GO:0016403 | dimethylargininase activity(GO:0016403) |
| 0.5 | 2.3 | GO:0051393 | alpha-actinin binding(GO:0051393) |
| 0.5 | 4.5 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
| 0.4 | 1.8 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
| 0.4 | 36.0 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.4 | 2.0 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 0.3 | 1.7 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 0.3 | 1.4 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.3 | 4.3 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.3 | 3.2 | GO:0031014 | troponin T binding(GO:0031014) |
| 0.3 | 0.5 | GO:0034061 | DNA-directed DNA polymerase activity(GO:0003887) DNA polymerase activity(GO:0034061) |
| 0.2 | 4.5 | GO:0005523 | tropomyosin binding(GO:0005523) |
| 0.2 | 0.9 | GO:0070492 | oligosaccharide binding(GO:0070492) |
| 0.2 | 1.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.2 | 2.7 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
| 0.2 | 3.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 0.2 | 0.5 | GO:0004962 | endothelin receptor activity(GO:0004962) |
| 0.1 | 3.2 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
| 0.1 | 1.7 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.1 | 1.6 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
| 0.1 | 0.5 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 0.1 | 0.4 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
| 0.1 | 0.3 | GO:0008301 | DNA binding, bending(GO:0008301) |
| 0.1 | 1.9 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.1 | 0.6 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
| 0.1 | 3.0 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
| 0.1 | 2.0 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.1 | 0.3 | GO:0004504 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
| 0.1 | 1.1 | GO:0005522 | profilin binding(GO:0005522) |
| 0.1 | 0.3 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 0.1 | 0.8 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, RNA polymerase II basal transcription factor binding(GO:0001083) transcription factor activity, TFIIB-class binding(GO:0001087) RNA polymerase II basal transcription factor binding(GO:0001091) TFIIB-class transcription factor binding(GO:0001093) |
| 0.1 | 1.1 | GO:0070063 | RNA polymerase binding(GO:0070063) |
| 0.1 | 0.4 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
| 0.1 | 1.7 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.1 | 0.9 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
| 0.1 | 0.7 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) histone deacetylase activity (H4-K16 specific)(GO:0034739) NAD-dependent histone deacetylase activity (H4-K16 specific)(GO:0046970) |
| 0.1 | 3.0 | GO:0043130 | ubiquitin binding(GO:0043130) |
| 0.1 | 0.4 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
| 0.1 | 1.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.0 | 0.4 | GO:0004835 | tubulin-tyrosine ligase activity(GO:0004835) |
| 0.0 | 1.5 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
| 0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 0.0 | 3.6 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.0 | 0.9 | GO:0030552 | cAMP binding(GO:0030552) |
| 0.0 | 0.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.0 | 0.2 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
| 0.0 | 0.2 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
| 0.0 | 1.0 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.0 | 0.9 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.0 | 0.5 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
| 0.0 | 0.6 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.0 | 0.2 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
| 0.0 | 0.9 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
| 0.0 | 0.6 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.0 | 0.5 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
| 0.0 | 0.2 | GO:0016413 | carnitine O-acyltransferase activity(GO:0016406) O-acetyltransferase activity(GO:0016413) |
| 0.0 | 0.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.0 | 2.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.0 | 0.1 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
| 0.0 | 0.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.0 | 0.3 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.0 | 0.1 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.0 | 1.4 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.0 | 0.4 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
| 0.0 | 0.9 | GO:0003777 | microtubule motor activity(GO:0003777) |
| 0.0 | 3.0 | GO:0008022 | protein C-terminus binding(GO:0008022) |
| 0.0 | 7.1 | GO:0008092 | cytoskeletal protein binding(GO:0008092) |
| 0.0 | 0.4 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.0 | 0.2 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
| 0.0 | 2.1 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.0 | 0.1 | GO:0005110 | frizzled-2 binding(GO:0005110) |
| 0.0 | 0.0 | GO:0019237 | centromeric DNA binding(GO:0019237) |
| 0.0 | 0.1 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 0.0 | 0.6 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
| 0.0 | 1.3 | GO:0051082 | unfolded protein binding(GO:0051082) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.0 | 1.1 | ST_GA13_PATHWAY | G alpha 13 Pathway |
| 0.0 | 2.2 | SIG_CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.0 | 1.6 | SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES | Genes related to the insulin receptor pathway |
| 0.0 | 2.8 | ST_INTEGRIN_SIGNALING_PATHWAY | Integrin Signaling Pathway |
